01 —
Gene Therapy
Viral Vector Filtration
AFRM™ addresses fouling at the mechanism level, maintaining sieving coefficient stability across the full batch duration.
McCarney L, et al. Sep. Purif. Technol. 2025.
DOI
Advanced regenerative architecture engineered to stabilize membrane performance, mitigate reversible fouling, and preserve the integrity of high-value shear-sensitive biofluids in GMP bioprocessing.
→ Watch the full technical video on TFF fouling mitigation
In-depth analysis of AFRM™ architecture and its impact on flux stabilization and permeability recovery.
Technical overview of AFRM™ — TFF fouling mitigation and process resilience for GMP biopharmaceutical manufacturing.
Alternatively, read the technical white paper.
Alternatively, read the technical white paper.
02 —
EV Therapeutics
Extracellular Vesicle Processing
Deterministic regeneration prevents the cake layer that would otherwise narrow effective pore diameter.
03 —
Perfusion Culture
High-Density Cell Retention
Maintains quasi-stationary flux throughout the campaign by preventing irreversible cake compaction.
04 —
mAb Downstream
Monoclonal Antibody Concentration
The regeneration schedule is pre-computed from fluid rheological parameters, eliminating empirical retuning.